Short answer
Separate three causes: the carrier does not want the class, the submission does not explain the risk, or the exposure falls outside the market’s tolerance. Ask which one applies, preserve the questions that came back, and rebuild the submission around the company’s actual operations, agent authority, controls, contracts, incidents, and unknowns. Better evidence cannot manufacture appetite, but it can prevent an information gap from looking like an uninsurable risk.
Evidence frame
- Established
- A decline can reflect carrier appetite, missing information, or an exposure outside the market’s tolerance. These are different underwriting decisions even when the email says only ‘declined.’
- Clara inference
- A legible record of authority, controls, contracts, incidents, dependencies, and unknowns can stop an information gap from being mistaken for an unacceptable class of risk.
- Hypothesis
- Evidence-linked submissions that preserve effective dates and provenance will create better conversations across markets than narrative descriptions assembled from disconnected questionnaires.
- Unknown
- A stronger submission cannot manufacture appetite or guarantee placement. Carrier thresholds, capacity, exclusions, pricing, and final terms remain market decisions.
Three different problems look like one decline
| Cause | What it means | Best next move |
|---|---|---|
| Appetite | The carrier or product is not filed or designed for the class, jurisdiction, scale, or authority. | Route the risk to a market whose appetite fits; do not rewrite facts to pass a screen. |
| Information gap | The reviewer cannot tell what the company does, what the agent can reach, or which controls are real. | Add a clear operations, authority, controls, contracts, and evidence packet. |
| Exposure concern | The loss potential, control weakness, contract, jurisdiction, or history exceeds the market’s tolerance. | Change the operation or controls, narrow the exposure, negotiate terms, or seek a different structure. |
A generic application often collapses all three into a few hazard words. “Autonomous,” “financial,” or “customer data” can describe a well-controlled operation or a very different one. The submission must show the difference.
What a reviewer needs to see
A decision-useful AI submission answers the ordinary business questions and the authority questions together:
- What does the company sell, to whom, in which jurisdictions, and under which contracts?
- Which AI systems are in production, and what work do they perform?
- What may each system decide, spend, promise, publish, change, deploy, or transact?
- Which tools, credentials, data, vendors, and production systems can it reach?
- What human approval, monitoring, testing, shutdown, and rollback controls are enforced?
- What incidents, near misses, disputes, claims, exceptions, and unknowns remain?
The answer should distinguish what is declared from what is enforced and what has been observed in operation. A policy document that says “human in the loop” is not the same evidence as a tested approval gate with logs and escalation.
Build the packet around evidence, not confidence language
Avoid replacing evidence with adjectives such as safe, responsible, enterprise-grade, or fully autonomous. State the mechanism and attach the proof: the control owner, effective date, test, scope, limitation, and unresolved exception.
RISK.md proposes this separation as a company-owned context packet. It does not turn self-reported facts into underwriting truth; it makes provenance and uncertainty visible so the reviewer can decide what requires validation.
The packet should be purpose-limited. Do not include secrets, credentials, unnecessary personal data, or sensitive security detail merely to look thorough.
What to do after a decline
- Record the carrier, product, date, jurisdiction, and stated reason.
- Ask whether the issue was appetite, a specific exposure, or missing information.
- Preserve the questions and objections; they are evidence about what the market needs to understand.
- Correct factual ambiguity without minimizing the actual authority or loss potential.
- Re-route appetite problems to a suitable market and remediate control or evidence problems before resubmitting.
Do not treat a decline as a reason to hide the system’s authority. A better submission is more honest, more bounded, and easier to compare across markets.
The evidence advantage must be earned
Clara is not claiming that a packet guarantees placement or better terms. The research question is whether a longitudinal record of authority, controls, incidents, and market questions improves the decisions made by founders, brokers, underwriters, and claims teams.
The Klaimee note shows one emerging interface between technical evaluation and insurance. Clara’s narrower bet is that company-owned evidence should remain inspectable and reusable even when different markets apply different appetite and judgment.
Common questions
Why was my AI insurance application declined?
The reason may be carrier appetite, missing or unclear information, a specific exposure, jurisdiction, contract, control weakness, or loss history. A decline alone does not identify which one occurred.
Does a decline mean my AI company is uninsurable?
No. It may mean the submission reached a market that does not want the class or could not evaluate the operation from the information provided. Some exposures may still require remediation or a different structure.
What should an AI insurance application include?
It should describe the company, customers, operations, contracts, AI systems, authority, tools, data, controls, testing, incidents, claims, dependencies, and known unknowns with evidence and effective dates.
Should a company remove the word AI from an application?
No. The goal is accurate description, not keyword avoidance. Explain the system’s actual work, authority, controls, and loss paths so a reviewer can distinguish the operation from a generic hazard label.
Can better documentation change an underwriting decision?
It can resolve an information gap and make controls, boundaries, and loss potential easier to evaluate. It cannot create appetite where a carrier does not want the class or eliminate an exposure the market will not accept.